ROSS STEVEN A 4
4 · NEOGENOMICS INC · Filed May 10, 2018
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Common Stock
2018-05-10$4.78/sh+33,667$160,928→ 38,167 total - Sale
Common Stock
2018-05-10$10.78/sh−81,999$883,949→ 4,500 total - Exercise of In-Money
Stock Option (Right to Buy)
2018-05-10$4.78/sh−33,667$160,928→ 0 totalExercise: $4.78From: 2016-05-06Exp: 2020-05-06→ Common Stock (33,667 underlying) - Exercise of In-Money
Stock Option (Right to Buy)
2018-05-10$7.15/sh−26,666$190,662→ 13,334 totalExercise: $7.15From: 2017-04-20Exp: 2021-04-20→ Common Stock (26,666 underlying) - Exercise of In-Money
Stock Option (Right to Buy)
2018-05-10$7.52/sh−21,666$162,928→ 43,334 totalExercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (21,666 underlying) - Exercise/Conversion
Common Stock
2018-05-10$7.15/sh+26,666$190,662→ 64,833 total - Exercise/Conversion
Common Stock
2018-05-10$7.52/sh+21,666$162,928→ 86,499 total
Holdings
- 72,500
Stock Option (Right to Buy)
Exercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (72,500 underlying) - 4,500
Common Stock
Footnotes (3)
- [F1]On April 20, 2016, Mr. Ross was granted 40,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Mr. Ross exercised 26,666 of these options in May 2018, leaving a balance of 13,334 options.
- [F2]On April 28, 2017, Mr. Ross was granted 65,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Mr. Ross exercised 21,666 of these options in May 2018, leaving a balance of 43,334 options.
- [F3]On February 26, 2018, Mr. Ross was granted 72,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.